Centre Hospitalier de l'Université de Montréal
Montreal, Quebec, Canada
26 recruiting
Showing 1–20 of 26 trials
Recruiting
Phase 1Phase 2
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Breast CancerLung Cancer
Bristol-Myers Squibb416 enrolled63 locationsNCT06618287
Recruiting
Not Applicable
WATER IV Prostate Cancer
Localized Prostate Cancer
PROCEPT BioRobotics280 enrolled36 locationsNCT06651632
Recruiting
Phase 2Phase 3
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Breast Neoplasms
Bristol-Myers Squibb500 enrolled293 locationsNCT06926868
Recruiting
Phase 3
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Prostate CancerCancer of the ProstateHormone Sensitive Prostate Cancer+1 more
Pfizer1,000 enrolled188 locationsNCT07028853
Recruiting
Phase 3
A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Pfizer600 enrolled235 locationsNCT06551324
Recruiting
Phase 3
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Metastatic Castration-resistant Prostate Cancer
Pfizer900 enrolled240 locationsNCT06629779
Recruiting
Prevalence of Postpartum Depression Among Patients of the CHUM GARE Clinic
Mental Health IssueMaternal HealthPost Partum Depression
Centre hospitalier de l'Université de Montréal (CHUM)100 enrolled1 locationNCT07200323
Recruiting
Phase 2
Post-operative Radiotherapy After Neodjuvant Chemo-immunotherapy and Surgery in Stage III NSCLC
Non-small Cell Lung CancerStage III Lung Cancer
Centre hospitalier de l'Université de Montréal (CHUM)118 enrolled1 locationNCT06878274
Recruiting
Phase 3
Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma
Endometrial Cancer
Karyopharm Therapeutics Inc276 enrolled217 locationsNCT05611931
Recruiting
Phase 3
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
Atrial FibrillationStrokeBleeding
Icahn School of Medicine at Mount Sinai3,200 enrolled101 locationsNCT04045665
Recruiting
Phase 4
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
Atrial FibrillationStroke
Population Health Research Institute2,270 enrolled105 locationsNCT03968393
Recruiting
Phase 1
A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors
Advanced Solid Tumors
Bristol-Myers Squibb213 enrolled11 locationsNCT06544655
Recruiting
Phase 1
A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.
Non-small Cell Lung Cancer (NSCLC)High-grade Serous Ovarian Carcinoma (HGSOC)Uterine Serous Carcinoma (USC)
Bristol-Myers Squibb240 enrolled16 locationsNCT06476808
Recruiting
Not Applicable
Proactive Risk-based Optimization & Notifications for Treatment & Outcomes in Head & Neck Cancer
Oral Cancer , Oral Squamous Cell Carcinoma, Oral Cavity CancerHead &Amp;Amp; Neck Squamous Cell CarcinomaLarynx Squamous Cell Carcinoma
Centre hospitalier de l'Université de Montréal (CHUM)85 enrolled1 locationNCT07180901
Recruiting
Phase 3
Stereotactic Boost and Short-course Radiation Therapy for Oropharynx Cancer
Head and Neck CancerOropharynx CancerHuman Papilloma Virus
Centre hospitalier de l'Université de Montréal (CHUM)360 enrolled2 locationsNCT04178174
Recruiting
Not Applicable
The Dragon PLC Trial (DRAGON-PLC)
CholangiocarcinomaHepatocellular Carcinoma (HCC)Primary Liver Cancer
Maastricht University358 enrolled55 locationsNCT06914648
Recruiting
Phase 1Phase 2
Innovative Patient-partner-guided Virtual Group Speech Pathology Intervention Model in Head and Neck Cancer
Dysphagia
Centre hospitalier de l'Université de Montréal (CHUM)76 enrolled1 locationNCT05621889
Recruiting
Phase 2
Focal HDR Brachytherapy Boost to Stereotactic Radiotherapy
Prostate Cancer
Centre hospitalier de l'Université de Montréal (CHUM)150 enrolled2 locationsNCT04100174
Recruiting
Registry of Patients Living With Type 1 Diabetes
Type 1 Diabetes Mellitus
Institut de Recherches Cliniques de Montreal6,000 enrolled7 locationsNCT03720197
Recruiting
Glycemic Control and Osteohealth in Adults Living With Type 1 Diabetes
Type 1 Diabetes
Centre hospitalier de l'Université de Montréal (CHUM)25 enrolled2 locationsNCT06158503